Sustained Disease Control with Niraparib in a Pediatric Patient withRecurrent Atypical Teratoid/Rhabdoid Tumor: A Case Report

Current Cancer Drug Targets · Published 2026-04-01 · DOI 10.2174/0115680096464641260306042404

Authors being retrieved — see the publisher record. https://doi.org/10.2174/0115680096464641260306042404

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Therapy-Induced Cellular Senescence in Non-Hodgkin Lymphomas, with Emphasis on Aggressive B-Cell Subtypes: Molecular Mechanisms and Emerging Drug Targets · Current Cancer Drug Targets · 2026 · Same journal
• Advances in Pharmacological Therapy for Recurrent High-Grade Meningiomas · Current Cancer Drug Targets · 2026 · Same journal
• Ectophosphatase Activity in Human Hepatocellular Carcinoma Huh7 Cells:Characterisation and Implications for the Tumour Microenvironment · Current Cancer Drug Targets · 2026 · Same journal
• Screening of Demethylation-related Biomarkers and Exploration ofRegulatory Mechanisms in Esophageal Cancer Patients Based on MachineLearning and Mendelian Randomization · Current Cancer Drug Targets · 2026 · Same journal
• A Novel Oncogene and Therapeutic Target, Germ Cell-Specific Gene 2 (GSG2), Plays Complex Roles in Promoting Malignant Progression of Glioma · Current Cancer Drug Targets · 2026 · Same journal
• Single-Cell and Computational Epigenomics in HGSOC: A Roadmap to Overcoming Chemoresistance · Current Cancer Drug Targets · 2026 · Same journal
• LncRNA ABCA9-AS1 as a ceRNA Promotes Gastric Cancer Progression bySponging miR-497-5p to Regulate KIF23 Expression · Current Cancer Drug Targets · 2026 · Same journal
• FAM117B and ZDHHC21 as Shared Targets in Periodontitis and Oropharyngeal Cancer: Cephaeline and Sanguinarine as Potential Therapeutics · Current Cancer Drug Targets · 2026 · Same journal
• Shared Genetic Architecture of Epilepsy and Glioma Revealed by Mendelian Randomization: Identifying Prognostic Biomarkers and Therapeutic Targets · Current Cancer Drug Targets · 2026 · Same journal
• Overcoming Immune Resistance in Bladder Cancer: From ExhaustedT-Cells and Microbiome Crosstalk to Next-Generation CombinationTherapies · Current Cancer Drug Targets · 2026 · Same journal